Supernus Pharmaceuticals (SUPN) P/S (2012 - 2026)
Supernus Pharmaceuticals (SUPN) P/S from May 1, 2012 to Jul 21, 2026. The TTM Supernus Pharmaceuticals (SUPN) P/S is 3.58. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Supernus Pharmaceuticals (SUPN)
| Year | P/S | Change |
|---|---|---|
| 2026 | 3.58 | -9.96% |
| 2025 | 3.97 | +30.42% |
| 2024 | 3.05 | +18.43% |
| 2023 | 2.57 | -10.79% |
| 2022 | 2.88 | +7.62% |
| 2021 | 2.68 | +4.79% |
| 2020 | 2.56 | -19.44% |
| 2019 | 3.17 | -25.36% |
| 2018 | 4.25 | -45.20% |
| 2017 | 7.76 | +16.28% |
| 2016 | 6.67 | +24.94% |
| 2015 | 5.34 | +1.70% |
| 2014 | 5.25 | -76.51% |
| 2013 | 22.35 | -84.93% |
| 2012 | 148.35 | N/A |
Comparison Supernus Pharmaceuticals (SUPN) P/S with competitors
Supernus Pharmaceuticals (SUPN) P/S is 3.58.